uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Investigation of Drug Release from PEO Tablet Matrices in the Presence of Vitamin E as Antioxidant
Univ Kent, Medway Sch Pharm, Chem & Drug Delivery Grp, Chatham ME4 4TB, Kent, England..
Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.;Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.;Tabriz Univ Med Sci, Fac Pharm, Tabriz, Iran..
Univ Kent, Medway Sch Pharm, Chem & Drug Delivery Grp, Chatham ME4 4TB, Kent, England..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
Show others and affiliations
2015 (English)In: Current Drug Delivery, ISSN 1567-2018, E-ISSN 1875-5704, Vol. 12, no 5, 591-599 p.Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

The objective of this study was to investigate the influence of drug type on the release of drug from PEO matrix tablets accompanied with the impact of vitamin E succinate as antioxidant. The result showed that the presence of vitamin E promoted a stable release rate of soluble drug propranolol HCl from aged PEO matrix tablets, which was similar to fresh sample, regardless of molecular weight ( MW) of PEO. However, the influence of the presence of vitamin E on the release rate of partially soluble drug, theophylline, was dependent on the MW of PEO; i.e., fast and unstable drug release was obtained in the case of low MW PEO 750 whereas stable drug release was obtained in the case of high MW PEO 303. The release of low water-soluble drug zonisamide was stable regardless of both the presence of vitamin E and the MW of PEO. The presence of vitamin E slightly slowed the release of zonisamide from aged PEO 303 matrices but not PEO 750 matrices. Therefore, in order to achieve a suitable controlled release profile from PEO matrices, not only the presence of vitamin E but also the solubility of the drug and the MW of polyox should be considered.

Place, publisher, year, edition, pages
2015. Vol. 12, no 5, 591-599 p.
Keyword [en]
Controlled release, Drug solubility, PEO matrices, Stability, Vitamin E
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-269294DOI: 10.2174/1567201812666150326113052ISI: 000364532700011PubMedID: 25808280OAI: oai:DiVA.org:uu-269294DiVA: diva2:882616
Available from: 2015-12-15 Created: 2015-12-15 Last updated: 2017-12-01Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Alhalaweh, Amjad

Search in DiVA

By author/editor
Alhalaweh, Amjad
By organisation
Department of Pharmacy
In the same journal
Current Drug Delivery
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 227 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf